Hillman, Patti, Weinreb receive ACR Gold Medal

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The American College of Radiology board of selected three innovators as 2017 Gold Medalists for their extraordinary service to the college or radiology. Honors will be presented bestowed during ACR 2017 – The Crossroads of Radiology meeting in Washington May 21-25, 2017.

The following individuals will receive the ACR Gold Medal:

  • Bruce Hillman, of Wake Forest, NC, professor of radiology and medical imaging and health evaluation sciences and former chair of radiology, University of Virginia, and founding and current editor-in-chief of the Journal of the American College of Radiology,

  • John Patti, of Lynnfield, MA, senior lecturer in radiology at Harvard Medical School and thoracic radiologist at Massachusetts General Hospital and Harvard Medical School, and past chair of the board and president of ACR,

  • Jeffrey C. Weinreb, of New Haven, CT, professor of radiology and biomedical imaging and vice chair for strategic planning and innovation at Yale-New Haven Hospital/Yale School of Medicine, and past BOC member and vice-president of ACR

The following candidates were approved to receive Honorary Fellowships in recognition of their contributions to the science or practice of radiology:

  • Berend J. Slotman, of Amsterdam, professor and chair of radiation oncology, VU University Medical Center Amsterdam,
  • Jacob Sosna, of Jerusalem, chair, division of imaging, Hadassah Hebrew University Medical Center, and president of the Israel Radiological Association.

In addition, Pamela Wilcox, of Ridge, MD, will receive the Distinguished Achievement Award for notable service to the college and the profession. Wilcox served as ACR executive vice president of quality and safety, retiring in 2015 after 28 years of service.

YOU MAY BE INTERESTED IN

For nearly 25 years, business executive Lou Weisbach and urologist Richard J. Boxer have argued that finding the money to finance the cures for devastating diseases is not as difficult as it appears. To start finding the cures, the U.S. Department of the Treasury needs to issue some bonds—$750 billion worth. Next, you hire CEOs—one...

There is general agreement that the United States spends too much on health care, especially on pharmaceuticals.  But what we spend on drugs is not simply a function of price. If eggs double in price, people can simply cut the number of eggs they eat in half.  Simply stated, cost is the product of (price per unit times the number of units purchased). 
What did President Richard M. Nixon and Senator Edward M. Kennedy have in common? They each played a pivotal role in the passage of the National Cancer Act signed by Nixon on Dec. 23, 1971. The NCA established the National Cancer Program authorizing the initial investment in the NCI-designated Cancer Centers Program. 
When I first proposed targeting PCNA (proliferating cell nuclear antigen) as a therapeutic approach, the response I got was: “No one will ever make a drug against PCNA. It’s undruggable.” The protein lacks enzymatic activity, has a disordered region, and binds to over 200 other proteins within the cell. From a traditional drug development perspective, these characteristics made PCNA an impossible target.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login